Company profile: Xagenic
1.1 - Company Overview
Company description
- Provider of on-demand molecular testing solutions that facilitate faster treatment decisions for patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Xagenic
Earth Science Tech
HQ: United States
Website
- Description: Provider of science-based biotechnology offerings bringing Nature's Pharmacy to the public, operating RxCompoundStore, a Miami compounding pharmacy licensed in 23 states; Peaks Curative, a telemedicine platform for men's and women's health offering ED products via a proprietary tadalafil gummy; Avenvi, a Miami real estate development firm; and Mister Meds, a Texas wellness-focused pharmacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Earth Science Tech company profile →
Novexel
HQ: France
Website
- Description: Provider of novel antiinfectives for severe and difficult-to-treat bacterial and fungal infections, engaging in the discovery and development of antibacterial and antifungal agents, supported by an extensive portfolio of compounds, R&D programs, and intellectual property.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Novexel company profile →
ProStrakan
HQ: United Kingdom
Website
- Description: Provider of specialty pharmaceutical development and commercialisation of prescription medicines for unmet therapeutic needs in major markets; headquartered in Scotland with more than 300 employees and commercial operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProStrakan company profile →
Proof Diagnostics
HQ: United States
Website
- Description: Provider of life sciences tools, diagnostics, and computational discovery solutions, offering a smart, portable CRISPR-based and other technology diagnostic system for rapid, low-cost, sensitive detection of infectious diseases (e.g., SARS-CoV-2, Flu A/B, RSV) and other diseases, OMEGA libraries of RNA-programmable non-Cas enzymes for genome engineering, and gene therapy services leveraging these tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proof Diagnostics company profile →
Targanta Therapeutics
HQ: United States
Website
- Description: Provider of innovative antibiotics and antibacterial therapies for serious infections treated or acquired in hospitals and other institutional settings, including oritavancin, an intravenous bactericidal agent for Gram-positive infections with Phase III trials for complicated skin and skin structure infections; antibacterial pro-drugs for osteomyelitis; and a drug discovery platform that mimics strategies devised by bacterial viruses to target druggable bacterial mechanisms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Targanta Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Xagenic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Xagenic
2.2 - Growth funds investing in similar companies to Xagenic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Xagenic
4.2 - Public trading comparable groups for Xagenic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →